The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Management of Stage III Non–Small-Cell Lung Cancer: ASCO Guideline
Abstract
PURPOSE: To provide evidence-based recommendations to practicing clinicians on management of patients with stage III non–small-cell lung cancer (NSCLC). METHODS: An Expert Panel of medical oncology, thoracic surgery, radiation oncology, pulmonary oncology, community oncology, research methodology, and advocacy experts was convened to conduct a literature search, which included systematic reviews, meta-analyses, and randomized controlled trials published from 1990 through 2021. Outcomes of interest included survival, disease-free or recurrence-free survival, and quality of life. Expert Panel members used available evidence and informal consensus to develop evidence-based guideline recommendations. RESULTS: The literature search identified 127 relevant studies to inform the evidence base for this guideline. RECOMMENDATIONS: Evidence-based recommendations were developed to address evaluation and staging workup of patients with suspected stage III NSCLC, surgical management, neoadjuvant and adjuvant approaches, and management of patients with unresectable stage III NSCLC. Additional information is available at www.asco.org/thoracic-cancer-guidelines .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cochrane Handbook for Systematic Reviews of Interventions
(2019) · doi:10.1002/9781119536604 · Cited by 14,828
GRADE guidelines: 3. Rating the quality of evidence
Balshem, H., Helfand, M., Schünemann, H. J., Oxman, A. D., Kunz, R., Brozek, J., Vist, G. E., Falck-Ytter, Y., Meerpohl, J., & Norris, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.015 · Cited by 8,285
Durvalumab after chemoradiotherapy in stage III non–small-cell lung cancer
Antonia, S. J., Villegas, A., Daniel, D., Vicente, D., Murakami, S., Hui, R., Yokoi, T., Chiappori, A., Lee, K. H., de Wit, M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1709937 · Cited by 4,593
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
Antonia, S. J., Villegas, A., Daniel, D., Vicente, D., Murakami, S., Hui, R., Kurata, T., Chiappori, A., Lee, K. H., de Wit, M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1809697 · Cited by 2,798
Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.
Pignon, J.-P., Tribodet, H., Scagliotti, G. V., Douillard, J.-Y., Shepherd, F. A., Stephens, R. J., Dunant, A., Torri, V., Rosell, R., Seymour, L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9030 · Cited by 2,642
(2004) · New England Journal of Medicine · doi:10.1056/nejmoa031644 · Cited by 2,335
Ferrell, B. R., Temel, J. S., Temin, S., Alesi, E. R., Balboni, T. A., Basch, E. M., Firn, J. I., Paice, J. A., Peppercorn, J. M., Phillips, T., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.1474 · Cited by 2,117
Self-citationBradley, J. D., Paulus, R., Komaki, R., Masters, G., Blumenschein, G., Schild, S., Bogart, J., Hu, C., Forster, K., Magliocco, A., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71207-0 · Cited by 2,015
Self-citationAupérin, A., Le Péchoux, C., Rolland, E., Curran, W. J., Furuse, K., Fournel, P., Belderbos, J., Clamon, G., Ulutin, H. C., Paulus, R., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.2543 · Cited by 1,878
Osimertinib in Resected EGFR -Mutated Non–Small-Cell Lung Cancer
Wu, Y.-L., Tsuboi, M., He, J., John, T., Grohe, C., Majem, M., Goldman, J. W., Laktionov, K., Kim, S.-W., Kato, T., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2027071 · Cited by 1,798
Douillard, J.-Y., Rosell, R., De Lena, M., Carpagnano, F., Ramlau, R., Gonzáles-Larriba, J. L., Grodzki, T., Pereira, J. R., Le Groumellec, A., Lorusso, V., et al. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70804-x · Cited by 1,573
Albain, K. S., Swann, R. S., Rusch, V. W., Turrisi, A. T., Shepherd, F. A., Smith, C., Chen, Y., Livingston, R. B., Feins, R. H., Gandara, D. R., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60737-6 · Cited by 1,470
Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer
Schaake-Koning, C., van den Bogaert, W., Dalesio, O., Festen, J., Hoogenhout, J., van Houtte, P., Kirkpatrick, A., Koolen, M., Maat, B., Nijs, A., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202203260805 · Cited by 1,277
Curran, W. J., Paulus, R., Langer, C. J., Komaki, R., Lee, J. S., Hauser, S., Movsas, B., Wasserman, T., Rosenthal, S. A., Gore, E., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr325 · Cited by 1,233
Dillman, R. O., Seagren, S. L., Propert, K. J., Guerra, J., Eaton, W. L., Perry, M. C., Carey, R. W., Frei, E. F., & Green, M. R. (1990) · New England Journal of Medicine · doi:10.1056/nejm199010043231403 · Cited by 1,153
Dillman, R. O., Herndon, J., Seagren, S. L., Eaton, W. L., & Green, M. R. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.17.1210 · Cited by 923
Schnipper, L. E., Davidson, N. E., Wollins, D. S., Tyne, C., Blayney, D. W., Blum, D., Dicker, A. P., Ganz, P. A., Hoverman, J. R., Langdon, R., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.6706 · Cited by 912
Chun, S. G., Hu, C., Choy, H., Komaki, R. U., Timmerman, R. D., Schild, S. E., Bogart, J. A., Dobelbower, M. C., Bosch, W., Galvin, J. M., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.1378 · Cited by 746
Self-citationvan Meerbeeck, J. P., Kramer, G. W. P. M., Van Schil, P. E. Y., Legrand, C., Smit, E. F., Schramel, F., Tjan-Heijnen, V. C., Biesma, B., Debruyne, C., van Zandwijk, N., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk093 · Cited by 705
Gould, M. K., Kuschner, W. G., Rydzak, C. E., Maclean, C. C., Demas, A. N., Shigemitsu, H., Chan, J. K., & Owens, D. K. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-11-200311180-00013 · Cited by 687
Schnipper, L. E., Davidson, N. E., Wollins, D. S., Blayney, D. W., Dicker, A. P., Ganz, P. A., Hoverman, J. R., Langdon, R., Lyman, G. H., Meropol, N. J., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.68.2518 · Cited by 655
American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care
Meropol, N. J., Schrag, D., Smith, T. J., Mulvey, T. M., Langdon, R. M., Blum, D., Ubel, P. A., & Schnipper, L. E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.1183 · Cited by 638
Final Results of Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer
Sause, W., Kolesar, P., Taylor, S., Johnson, D., Livingston, R., Komaki, R., Emami, B., Curran, W., Byhardt, R., Dar, A. R., et al. (2000) · Chest · doi:10.1378/chest.117.2.358 · Cited by 627
Patient-clinician communication: American Society of Clinical Oncology consensus guideline
Gilligan, T., Coyle, N., Frankel, R. M., Berry, D. L., Bohlke, K., Epstein, R. M., Finlay, E., Jackson, V. A., Lathan, C. S., Loprinzi, C. L., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.75.2311 · Cited by 610
Scagliotti, G. V. (2003) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/djg059 · Cited by 593
Bradley, J. D., Hu, C., Komaki, R. R., Masters, G. A., Blumenschein, G. R., Schild, S. E., Bogart, J. A., Forster, K. M., Magliocco, A. M., Kavadi, V. S., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.01162 · Cited by 591
Self-citationSaunders, M., Dische, S., Barrett, A., Harvey, A., Gibson, D., & Parmar, M. (1997) · The Lancet · doi:10.1016/s0140-6736(97)06305-8 · Cited by 584
Kelly, K., Chansky, K., Gaspar, L. E., Albain, K. S., Jett, J., Ung, Y. C., Lau, D. H. M., Crowley, J. J., & Gandara, D. R. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.4824 · Cited by 573
Fournel, P., Robinet, G., Thomas, P., Souquet, P.-J., Léna, H., Vergnenégre, A., Delhoume, J.-Y., Le Treut, J., Silvani, J.-A., Dansin, E., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.070 · Cited by 542
Butts, C., Socinski, M. A., Mitchell, P. L., Thatcher, N., Havel, L., Krzakowski, M., Nawrocki, S., Ciuleanu, T.-E., Bosquée, L., Trigo, J. M., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70510-2 · Cited by 538
Zhong, W.-Z., Wang, Q., Mao, W.-M., Xu, S.-T., Wu, L., Shen, Y., Liu, Y.-Y., Chen, C., Cheng, Y., Xu, L., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30729-5 · Cited by 529
Vansteenkiste, J. F., Cho, B. C., Vanakesa, T., De Pas, T., Zielinski, M., Kim, M. S., Jassem, J., Yoshimura, M., Dahabreh, J., Nakayama, H., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)00099-1 · Cited by 511
Cost Sharing and Adherence to Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia
Dusetzina, S. B., Winn, A. N., Abel, G. A., Huskamp, H. A., & Keating, N. L. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.9123 · Cited by 500
Kalemkerian, G. P., Narula, N., Kennedy, E. B., Biermann, W. A., Donington, J., Leighl, N. B., Lew, M., Pantelas, J., Ramalingam, S. S., Reck, M., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.7293 · Cited by 492
Self-citationHanna, N., Neubauer, M., Yiannoutsos, C., McGarry, R., Arseneau, J., Ansari, R., Reynolds, C., Govindan, R., Melnyk, A., Fisher, W., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.7840 · Cited by 491
Saunders, M., Dische, S., Barrett, A., Harvey, A., Griffiths, G., & Parmar, M. (1999) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(99)00087-0 · Cited by 480
Kelly, K., Altorki, N. K., Eberhardt, W. E. E., O'Brien, M. E. R., Spigel, D. R., Crinò, L., Tsai, C.-M., Kim, J.-H., Cho, E. K., Hoffman, P. C., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.8918 · Cited by 480
Vokes, E. E., Herndon, J. E., Kelley, M. J., Cicchetti, M. G., Ramnath, N., Neill, H., Atkins, J. N., Watson, D. M., Akerley, W., & Green, M. R. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.3569 · Cited by 478
Lally, B. E., Zelterman, D., Colasanto, J. M., Haffty, B. G., Detterbeck, F. C., & Wilson, L. D. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.6110 · Cited by 469
Self-citationFaivre-Finn, C., Vicente, D., Kurata, T., Planchard, D., Paz-Ares, L., Vansteenkiste, J. F., Spigel, D. R., Garassino, M. C., Reck, M., Senan, S., et al. (2021) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.12.015 · Cited by 459
Rusch, V. W., Giroux, D. J., Kraut, M. J., Crowley, J., Hazuka, M., Winton, T., Johnson, D. H., Shulman, L., Shepherd, F., Deschamps, C., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.2826 · Cited by 457
Roth, J. A., Atkinson, E. N., Fossella, F., Komaki, R., Ryan, M. B., Putnam, J. B., Lee, J. S., Dhingra, H., De Caro, L., Chasen, M., et al. (1998) · Lung Cancer · doi:10.1016/s0169-5002(98)00046-4 · Cited by 447
Treatment of Stage III Non-small Cell Lung Cancer
Ramnath, N., Dilling, T. J., Harris, L. J., Kim, A. W., Michaud, G. C., Balekian, A. A., Diekemper, R., Detterbeck, F. C., & Arenberg, D. A. (2013) · Chest · doi:10.1378/chest.12-2360 · Cited by 442
Self-citationBradley, J., Graham, M. V., Winter, K., Purdy, J. A., Komaki, R., Roa, W. H., Ryu, J. K., Bosch, W., & Emami, B. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.06.260 · Cited by 441
Self-citationSenan, S., Brade, A., Wang, L.-H., Vansteenkiste, J., Dakhil, S., Biesma, B., Martinez Aguillo, M., Aerts, J., Govindan, R., Rubio-Viqueira, B., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.8824 · Cited by 433
Felip, E., Rosell, R., Maestre, J. A., Rodríguez-Paniagua, J. M., Morán, T., Astudillo, J., Alonso, G., Borro, J. M., González-Larriba, J. L., Torres, A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.6204 · Cited by 430
Arriagada, R., Dunant, A., Pignon, J.-P., Bergman, B., Chabowski, M., Grunenwald, D., Kozlowski, M., Le Péchoux, C., Pirker, R., Pinel, M.-I. S., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.2272 · Cited by 394
ROSELL, R., GOMEZCODINA, J., CAMPS, C., JAVIERSANCHEZ, J., MAESTRE, J., PADILLA, J., CANTO, A., ABAD, A., & ROIG, J. (1999) · Lung Cancer · doi:10.1016/s0169-5002(99)00045-8 · Cited by 393
Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial
Pless, M., Stupp, R., Ris, H.-B., Stahel, R. A., Weder, W., Thierstein, S., Gerard, M.-A., Xyrafas, A., Früh, M., Cathomas, R., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60294-x · Cited by 390
Self-citationWALLER, D., PEAKE, M., STEPHENS, R., GOWER, N., MILROY, R., PARMAR, M., RUDD, R., SPIRO, S., & ONBEHALFOFALLBLTPARTICIPANTS (2004) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2004.03.041 · Cited by 387
Special Treatment Issues in Non-small Cell Lung Cancer
Kozower, B. D., Larner, J. M., Detterbeck, F. C., & Jones, D. R. (2013) · Chest · doi:10.1378/chest.12-2362 · Cited by 372
Self-citationKris, M. G., Gaspar, L. E., Chaft, J. E., Kennedy, E. B., Azzoli, C. G., Ellis, P. M., Lin, S. H., Pass, H. I., Seth, R., Shepherd, F. A., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.72.4401 · Cited by 368
Eberhardt, W. E. E., Pöttgen, C., Gauler, T. C., Friedel, G., Veit, S., Heinrich, V., Welter, S., Budach, W., Spengler, W., Kimmich, M., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.62.6812 · Cited by 365
Thomas, M., Rübe, C., Hoffknecht, P., Macha, H. N., Freitag, L., Linder, A., Willich, N., Hamm, M., Sybrecht, G. W., Ukena, D., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70156-6 · Cited by 346
Patel, M. I., Lopez, A. M., Blackstock, W., Reeder-Hayes, K., Moushey, E. A., Phillips, J., & Tap, W. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00642 · Cited by 338
Aupérin, A., Le Péchoux, C., Pignon, J. P., Koning, C., Jeremic, B., Clamon, G., Einhorn, L., Ball, D., Trovo, M. G., Groen, H. J. M., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdj117 · Cited by 293
Zhong, W.-Z., Chen, K.-N., Chen, C., Gu, C.-D., Wang, J., Yang, X.-N., Mao, W.-M., Wang, Q., Qiao, G.-B., Cheng, Y., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.19.00075 · Cited by 268
Ahn, J. S., Ahn, Y. C., Kim, J.-H., Lee, C. G., Cho, E. K., Lee, K. C., Chen, M., Kim, D.-W., Kim, H.-K., Min, Y. J., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.60.0130 · Cited by 261
Patient and Plan Characteristics Affecting Abandonment of Oral Oncolytic Prescriptions
Streeter, S. B., Schwartzberg, L., Husain, N., & Johnsrud, M. (2011) · Journal of Oncology Practice · doi:10.1200/jop.2011.000316 · Cited by 248
Robinson, C. G., Patel, A. P., Bradley, J. D., DeWees, T., Waqar, S. N., Morgensztern, D., Baggstrom, M. Q., Govindan, R., Bell, J. M., Guthrie, T. J., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.5380 · Cited by 244
Self-citationThe PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer
van Elmpt, W., De Ruysscher, D., van der Salm, A., Lakeman, A., van der Stoep, J., Emans, D., Damen, E., Öllers, M., Sonke, J.-J., & Belderbos, J. (2012) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2012.03.005 · Cited by 229
Liang, J., Bi, N., Wu, S., Chen, M., Lv, C., Zhao, L., Shi, A., Jiang, W., Xu, Y., Zhou, Z., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx009 · Cited by 196
Defining Local-Regional Control and Its Importance in Locally Advanced Non-small Cell Lung Carcinoma
Machtay, M., Paulus, R., Moughan, J., Komaki, R., Bradley, J. E., Choy, H., Albain, K., Movsas, B., Sause, W. T., & Curran, W. J. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182429682 · Cited by 192
Self-citationNagai, K., Tsuchiya, R., Mori, T., Tada, H., Ichinose, Y., Koike, T., & Kato, H. (2003) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2003.15 · Cited by 187
Mohile, S. G., Dale, W., Somerfield, M. R., & Hurria, A. (2018) · Journal of Oncology Practice · doi:10.1200/jop.18.00180 · Cited by 187
Shiffman, R. N., Michel, G., Rosenfeld, R. M., & Davidson, C. (2012) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2011-000172 · Cited by 184
Movsas, B., Hu, C., Sloan, J., Bradley, J., Komaki, R., Masters, G., Kavadi, V., Narayan, S., Michalski, J., Johnson, D. W., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2015.3969 · Cited by 182
Self-citationWakelee, H. A., Dahlberg, S. E., Keller, S. M., Tester, W. J., Gandara, D. R., Graziano, S. L., Adjei, A. A., Leighl, N. B., Aisner, S. C., Rothman, J. M., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30691-5 · Cited by 171
Self-citationBaumann, M. A., Herrmann, T., Koch, R., Matthiessen, W., Appold, S., Wahlers, B., Kępka, L., Marschke, G., Feltl, D., Fietkau, R., et al. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.06.031 · Cited by 155
Rusch, V. W., Parekh, K. R., León, L. F., Venkatraman, E. S., Bains, M. S., Downey, R. J., Boland, P. J., Bilsky, M. H., & Ginsberg, R. J. (2000) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2000.106089 · Cited by 154
Chevalier, T. L., Arriagada, R., Quoix, E., Ruffiè, P., Martin, M., Douillard, J., Tarayre, M., Terrier‐Lacombe, M., & Laplanche, A. (1994) · Lung Cancer · doi:10.1016/0169-5002(94)91687-x · Cited by 145
Korevaar, D. A., Crombag, L. M. M. J., Cohen, J. F., Spijker, R., Bossuyt, P. M., & Annema, J. T. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)30317-4 · Cited by 141
Katakami, N., Tada, H., Mitsudomi, T., Kudoh, S., Senba, H., Matsui, K., Saka, H., Kurata, T., Nishimura, Y., & Fukuoka, M. (2012) · Cancer · doi:10.1002/cncr.26689 · Cited by 131
Komaki, R. U., Scott, C., Sause, W. T., Johnson, D. H., Taylor, S. G., Lee, J. S., Emami, B., Byhardt, R. W., Curran, W. J., Dar, A. R., et al. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)00365-9 · Cited by 131
Wu, Y., Li, P., Zhang, H., Shi, Y., Wu, H., Zhang, J., Qian, Y., Li, C., & Yang, J. (2013) · International Journal of Cancer · doi:10.1002/ijc.27779 · Cited by 129 · cited 1×
“A MA of 56 studies including 8,699 patients demonstrated improved detection of occult metastasis with the use of integrated PET-CT scan compared with clinical staging without PET scan.(133) PET-CT scan, however, is not adequate to exclude CNS metastases, given the high obligate utilization of glucose by the brain.”
BackgroundHiggins, K. A., O’Connell, K., Liu, Y., Gillespie, T. W., McDonald, M. W., Pillai, R. N., Patel, K. R., Patel, P. R., Robinson, C. G., Simone, C. B., et al. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.10.001 · Cited by 129
Self-citationEBUS-centred versus EUS-centred mediastinal staging in lung cancer: a randomised controlled trial
Kang, H. J., Hwangbo, B., Lee, G.-K., Nam, B., Lee, H., Kim, M. S., Lee, J. M., Zo, J. I., Lee, H. S., & Han, J. (2013) · Thorax · doi:10.1136/thoraxjnl-2013-203881 · Cited by 114
Kenmotsu, H., Yamamoto, N., Yamanaka, T., Yoshiya, K., Takahashi, T., Ueno, T., Goto, K., Daga, H., Ikeda, N., Sugio, K., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.02674 · Cited by 112
Mitchell, P., Thatcher, N., Socinski, M. A., Wasilewska-Teśluk, E., Horwood, K., Szczęsna, A., Martin, C. M., Ragulin, Y. А., Zukin, M., Helwig, C., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv104 · Cited by 111
Steuer, C. E., Behera, M., Ernani, V., Higgins, K. A., Saba, N. F., Shin, D. M., Pakkala, S., Pillai, R. N., Owonikoko, T. K., Curran, W. J., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.4280 · Cited by 109
Preoperative Staging by EBUS in cN0/N1 Lung Cancer: Systematic Review and Meta-Analysis
Leong, T. L., Loveland, P. M., Gorelik, A., Irving, L. B., & Steinfort, D. (2018) · Journal of Bronchology & Interventional Pulmonology · doi:10.1097/lbr.0000000000000545 · Cited by 109
Spigel, D. R., Finn, C. F., Gray, J. E., Vicente, D., Planchard, D., Paz-Ares, L. G., Vansteenkiste, J., Garassino, M. C., Hui, R., Quantin, X., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.2021.39.15_suppl.8511 · Cited by 109
Iyengar, P., Zhang-Velten, E. R., Court, L. E., Westover, K. D., Yan, Y., Lin, M., Xiong, Z., Patel, M., Rivera, D., Chang, J. Y., et al. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2021.3186 · Cited by 101
Kim, A. W., Boffa, D. J., Wang, Z., & Detterbeck, F. C. (2011) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2011.09.002 · Cited by 99
Self-citationRamroth, J., Cutter, D. J., Darby, S. C., Higgins, G. S., McGale, P., Partridge, M., & Taylor, C. W. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.07.022 · Cited by 94
Pechoux, C. L., Pourel, N., Barlési, F., Finn, C. F., Lerouge, D., Zalcman, G., Antoni, D., Lamezec, B., Nestle, U., Boisselier, P., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.08.2280 · Cited by 94
Schild, S. E., Stella, P. J., Geyer, S. M., Bonner, J. A., Marks, R. S., McGinnis, W. L., Goetz, S. P., Kuross, S. A., Mailliard, J. A., Kugler, J. W., et al. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)02930-9 · Cited by 92
Stinchcombe, T. E., Zhang, Y., Vokes, E. E., Schiller, J. H., Bradley, J. D., Kelly, K. L., Curran, W. J., Schild, S. E., Movsas, B., Clamon, G. H., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.71.4758 · Cited by 86
Self-citationPan, C.-C., Kung, P., Wang, Y., Chang, Y.-C., Wang, S.-T., & Tsai, W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126547 · Cited by 82
van Diessen, J., Ruysscher, D. D., Sonke, J., Damen, E. M. F., Sikorska, K., Reymen, B. J. T., van Elmpt, W., Westman, G., Persson, G. F., Dieleman, E. M. T., et al. (2018) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2018.09.019 · Cited by 82
Jalal, S. I., Riggs, H., Melnyk, A., Richards, D., Agarwala, A. K., Neubauer, M., Ansari, R., Govindan, R., Bruetman, D., Fisher, W. B., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr565 · Cited by 79
Girard, N., Mornex, F., Douillard, J., Bossard, N., Quoix, É., Beckendorf, V., Grunenwald, D. H., Amour, E., & Milleron, B. J. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2009.10.003 · Cited by 78
Induction chemotherapy for T4 centrally located non–small cell lung cancer
Rendina, E. A., Venuta, F., Giacomo, T. D., Ciccone, A. M., Ruvolo, G., Coloni, G. F., & Ricci, C. (1999) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(99)70416-2 · Cited by 78
Flentje, M. P., Huber, R. M., Engel-Riedel, W., Andreas, S., Kollmeier, J., Staar, S., Dickgreber, N. J., Vaissière, N., Almeida, C. D., Edlich, B., et al. (2016) · Strahlentherapie und Onkologie · doi:10.1007/s00066-016-0941-8 · Cited by 77
* (1995) · European Journal of Surgical Oncology · doi:10.1016/s0748-7983(05)80072-1 · Cited by 76
The Optimal Treatment for Stage IIIA-N2 Non-Small Cell Lung Cancer: A Network Meta-Analysis
Zhao, Y., Wang, W., Liang, H., Yang, C. J., D’Amico, T. A., Ng, C. S. H., Liu, C., Petersen, R. H., Rocco, G., Brunelli, A., et al. (2018) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2018.11.024 · Cited by 64
Hung, H.-Y., Tseng, Y.-H., Chao, H., Chiu, C., Hsu, W., Hsu, H., Wu, Y., Chou, T., Chen, C.-K., Lan, K.-L., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0236503 · Cited by 61
Chen, Y., Peng, X., Zhou, Y., Xia, K., & Zhuang, W. (2018) · World Journal of Surgical Oncology · doi:10.1186/s12957-018-1313-x · Cited by 57
Mattson, K. V., Abratt, R. P., ten Velde, G., et al. (2002) · Annals of Oncology · doi:10.1093/annonc/mdg009 · Cited by 52
Kim, T., Yang, S. H., Lee, S., Park, Y., Im, Y. H., Kang, W.-K., Ha, S. H., Park, C. I., Heo, D. S., Bang, Y., et al. (2002) · American Journal of Clinical Oncology · doi:10.1097/00000421-200206000-00007 · Cited by 49
Dawe, D. E., Christiansen, D. L., Swaminath, A., Ellis, P. M., Rothney, J., Rabbani, R., Abou-Setta, A. M., Zarychanski, R., & Mahmud, S. M. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.07.016 · Cited by 46
Figueiredo, V. R., Cardoso, P. F. G., Jacomelli, M., Santos, L. M., Minata, M. K., & Terra, R. M. (2020) · Jornal Brasileiro de Pneumologia · doi:10.36416/1806-3756/e20190221 · Cited by 43
Liang, H., Zhou, H., Li, X., Yin, Z., Guan, P., & Zhou, B. (2009) · International Journal of Cancer · doi:10.1002/ijc.25087 · Cited by 36
Senan, S., Cardenal, F., Vansteenkiste, J., Stigt, J. A., Akyol, F. H., Neve, W. D., Bakker, J., Dupont, J.-M., Scagliotti, G. V., Ricardi, U., et al. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq388 · Cited by 35
Cost-effectiveness of mediastinal lymph node staging in non–small cell lung cancer
Czarnecka‐Kujawa, K., Rochau, U., Siebert, U., Atenafu, E. G., Darling, G. E., Waddell, T. K., Pierre, A. F., de Perrot, M. E., Cypel, M., Keshavjee, S. H., et al. (2017) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2016.12.048 · Cited by 34
Carter, D. L., Garfield, D. H., Hathorn, J. W., Mundis, R. J., Boehm, K. A., Ilegbodu, D., Asmar, L., & Reynolds, C. H. (2011) · Clinical Lung Cancer · doi:10.1016/j.cllc.2011.10.005 · Cited by 30
Diaz, M. E., Debowski, M., Hukins, C., Fielding, D. I., Fong, K. M., & Bettington, C. S. (2018) · Journal of Medical Imaging and Radiation Oncology · doi:10.1111/1754-9485.12732 · Cited by 30
Hendriks, L. E. L., Bootsma, G. P., Ruysscher, D. D., Scheppers, N. A. M., Hofman, P. A. M., Brans, B. T., & Dingemans, A. C. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.02.006 · Cited by 28
Sakib, N., Li, N., Zhu, X., Li, D., Li, Y., & Wang, H. (2017) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000000764 · Cited by 24
Liu, T., He, Z., Dang, J., & Li, G. (2019) · Radiation Oncology · doi:10.1186/s13014-019-1239-7 · Cited by 24
Hung, M., Wu, Y.-F., & Chen, Y.-C. (2019) · Medicine · doi:10.1097/md.0000000000016167 · Cited by 21
Zhang, H., Zhang, D. X., Ju, T., & Zhou, J. (2019) · Neoplasma · doi:10.4149/neo_2018_181213n965 · Cited by 19
Motta, J. P. S., Steffen, R. E., Lobato, C. S. S., Mendonça, V. S., & Silva, J. R. L. E. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235479 · Cited by 19
Wang, X., Ding, X., Kong, D., Zhang, L., Guo, Y., Ren, J., Hu, X., Yang, J., & Gao, S. (2016) · International Journal of Clinical Oncology · doi:10.1007/s10147-016-1074-x · Cited by 15
Zehentmayr, F., Grambozov, B., Kaiser, J., et al. (2020) · Thoracic Cancer · doi:10.1111/1759-7714.13451 · Cited by 12
Ying, M., Liu, J., Zhou, W., Weng, K., Long, B., & Wang, Y. (2019) · Cancer Investigation · doi:10.1080/07357907.2019.1656730 · Cited by 6
Cited by
Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer
Heymach, J. V., Harpole, D., Mitsudomi, T., Taube, J. M., Galffy, G., Hochmair, M., Winder, T., Zukov, R., Garbaos, G., Gao, S., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2304875 · Cited by 778
Osimertinib after Chemoradiotherapy in Stage III EGFR -Mutated NSCLC
Lu, S., Kato, T., Dong, X., Ahn, M.-J., Quang, L.-V., Soparattanapaisarn, N., Inoue, T., Wang, C.-L., Huang, M., Yang, J. C.-H., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2402614 · Cited by 346
Metadata
- Authors
- Daly, M. E., Singh, N., Ismaila, N., Antonoff, M. B., Arenberg, D. A., Bradley, J., David, E., Detterbeck, F., Früh, M., Gubens, M. A., Moore, A. C., Padda, S. K., Patel, J. D., Phillips, T., Qin, A., Robinson, C., & Simone, C. B.
- Venue
- Journal of Clinical Oncology
- Published
- 2022-04-20
- Volume
- 40
- Issue
- 12
- Pages
- 1356-1384
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W4200347883
- Cited by
- 283
- References
- 117
- FWCI
- 23.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.